PDX1 and pancreatic neoplasm: The combination of BrBzGCp2 and IKE extended survival compared to either agent alone in C57BL/6J mice with orthotopically implanted KPC cells from pancreatic tumors of KPC mice (Pdx1‐Cre;K‐RasG12D/+;p53R172H/+) (Figure 6b).